Comment on 'A meta-analysis of CXCL12 expression for cancer prognosis'.
作者信息
Mei Zu-Bing, Luo Chun-Sheng, Wang Qing-Ming, Yang Wei
机构信息
Department of Anorectal Surgery, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
出版信息
Br J Cancer. 2018 Feb 6;118(3):e7. doi: 10.1038/bjc.2017.444. Epub 2018 Jan 4.
Abstract
摘要
相似文献
1
Comment on 'A meta-analysis of CXCL12 expression for cancer prognosis'.关于“CXCL12表达与癌症预后的荟萃分析”的评论
Br J Cancer. 2018 Feb 6;118(3):e7. doi: 10.1038/bjc.2017.444. Epub 2018 Jan 4.
2
Reply to 'Comment on 'A meta-analysis of CXCL12 expression for cancer prognosis".对《关于CXCL12表达对癌症预后的荟萃分析》的评论的回复
Br J Cancer. 2018 Feb 6;118(3):e8. doi: 10.1038/bjc.2017.445. Epub 2018 Jan 4.
3
A meta-analysis of CXCL12 expression for cancer prognosis.CXCL12表达与癌症预后的荟萃分析。
Br J Cancer. 2017 Jun 27;117(1):124-135. doi: 10.1038/bjc.2017.134. Epub 2017 May 23.
4
Prognostic and clinicopathological value of CXCL12/SDF1 expression in breast cancer: A meta-analysis.CXCL12/SDF1 表达在乳腺癌中的预后和临床病理价值：一项荟萃分析。
Clin Chim Acta. 2018 Sep;484:72-80. doi: 10.1016/j.cca.2018.05.041. Epub 2018 May 22.
5
Stromal CXCR4 and CXCL12 expression is associated with distant recurrence and poor prognosis in rectal cancer after chemoradiotherapy.基质细胞 CXCR4 和 CXCL12 的表达与直肠癌放化疗后远处复发和预后不良相关。
Ann Surg Oncol. 2010 Aug;17(8):2051-8. doi: 10.1245/s10434-010-0970-y. Epub 2010 Feb 23.
6
Clinical implication of CXCL12 expression in gastric cancer.CXCL12在胃癌中的表达的临床意义
Ann Surg Oncol. 2007 Nov;14(11):3154-8. doi: 10.1245/s10434-007-9521-6. Epub 2007 Jul 26.
7
CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival.乳腺癌中CXCL12/SDF1的表达是无病生存期和总生存期的独立预后标志物。
Eur J Cancer. 2009 Sep;45(14):2579-87. doi: 10.1016/j.ejca.2009.06.026. Epub 2009 Jul 29.
8
Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.CXCL12及其受体CXCR4在食管鳞状细胞癌中的表达
Oncol Rep. 2009 Jan;21(1):65-71.
9
CXCL12 expression promotes esophageal squamous cell carcinoma proliferation and worsens the prognosis.CXCL12表达促进食管鳞状细胞癌增殖并恶化预后。
BMC Cancer. 2016 Jul 21;16:514. doi: 10.1186/s12885-016-2555-z.
10
Aberrant methylation of CXCL12 in non-small cell lung cancer is associated with an unfavorable prognosis.非小细胞肺癌中CXCL12的异常甲基化与不良预后相关。
Int J Oncol. 2008 Jul;33(1):113-9.
引用本文的文献
1
Reply to 'Comment on 'A meta-analysis of CXCL12 expression for cancer prognosis".对《关于CXCL12表达对癌症预后的荟萃分析》的评论的回复
Br J Cancer. 2018 Feb 6;118(3):e8. doi: 10.1038/bjc.2017.445. Epub 2018 Jan 4.
本文引用的文献
1
A meta-analysis of CXCL12 expression for cancer prognosis.CXCL12表达与癌症预后的荟萃分析。
Br J Cancer. 2017 Jun 27;117(1):124-135. doi: 10.1038/bjc.2017.134. Epub 2017 May 23.
2
SDF-1 Expression is Associated with Poor Prognosis in Osteosarcoma.基质细胞衍生因子-1的表达与骨肉瘤的不良预后相关。
Ann Clin Lab Sci. 2016 Sep;46(5):508-14.
3
Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysis.肿瘤PIK3CA突变在结直肠癌中的预后作用：一项系统评价和荟萃分析。
Ann Oncol. 2016 Oct;27(10):1836-48. doi: 10.1093/annonc/mdw264. Epub 2016 Jul 19.
4
Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis.结直肠癌肿瘤浸润炎症与预后：系统评价和荟萃分析。
Br J Cancer. 2014 Mar 18;110(6):1595-605. doi: 10.1038/bjc.2014.46. Epub 2014 Feb 6.
5
Stromal CXCR4 and CXCL12 expression is associated with distant recurrence and poor prognosis in rectal cancer after chemoradiotherapy.基质细胞 CXCR4 和 CXCL12 的表达与直肠癌放化疗后远处复发和预后不良相关。
Ann Surg Oncol. 2010 Aug;17(8):2051-8. doi: 10.1245/s10434-010-0970-y. Epub 2010 Feb 23.
6
Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors.Meta回归分析发现，异质性治疗效果与研究层面因素之间存在关联，但与患者层面因素无关。
J Clin Epidemiol. 2004 Jul;57(7):683-97. doi: 10.1016/j.jclinepi.2003.12.001.
Zotero 插件